Protein Quantification: Evolution, Current Technologies, and Future Directions

Introduction

Accurate quantification of proteins is critical in biomedical research, clinical diagnostics, and in the development of protein-based therapeutics. Traditional protein quantification methods, still in use today, include colorimetric assays, direct spectrometry (UV-Vis), and immunoassays. Technological and analytical advances in mass spectrometry (MS), microfluidics, and single-molecule detection now enable rapid, high-accuracy analysis of complex samples. Emerging digital technologies, including artificial intelligence (AI), cloud-based platforms, and integrated technologies, continue to transform the way we quantify proteins, better understand protein functions, explore disease mechanisms, and discover novel therapeutic targets.

The evolution of protein quantification

The quantification of proteins started with foundational chemical techniques advancing toward highly specific immunoassays. The Lowry, BCA, and Bradford assays are routinely used colorimetric assays today, that are cost-effective and simple while offering good sensitivity and buffer compatibility, however they require the use of a protein standard.^1-3 Considering the variation in individual protein structure, the assumption that identical signals will be generated in a standard and sample is often a major issue decreasing the accuracy of these assays.

Alternatives to colorimetric assays include UV absorbance at 280 nm (UV280) and enzyme-linked immunosorbent assays (ELISAs). UV-vis at 280 nm leverages the intrinsic absorbance of aromatic amino acids for rapid, non-destructive quantification of purified protein samples without a standard, although it is highly error prone when used with complex samples.⁴ ELISAs, on the other hand, employ enzyme-conjugated antibodies for specific, accurate quantification of proteins, and remains the standard for clinical diagnostics and detecting host cell impurities in drug development despite limited throughput and a time-demanding workflow.^4,5

Current landscape of protein quantification

As protein-based therapeutics become prevalent in clinical applications, there is a need for high-throughput, reliable methods that can identify and quantify proteins in complex samples. Modern approaches now emphasize both quantification and in-depth analysis, and these techniques must accurately analyze complex samples and detect low-abundance impurities.

The introduction of fluorescence-based dyes such as SYPRO Orange and NanoOrange offer higher sensitivity compared to colorimetric assays and can efficiently detect low-abundance proteins in complex biological samples. In addition to fluorescence-based assays, Fourier Transform Infrared (FTIR) spectroscopy offers label-free, non-destructive protein quantification by analyzing peptide bond vibrations.

MS is central to modern proteomics with methods such as tandem mass tag (TMT), isobaric tags for relative and absolute quantitation (iTRAQ), and stable labeling by amino acids in cell culture (SILAC) enabling multiplexed quantification across multiple samples.⁶ Label-free quantification (LFQ), including spectral counting and ion intensity-based quantification, relies on the intrinsic signal intensity of peptides and is widely used in large-scale studies. Targeted approaches like parallel reaction monitoring (PRM) and selected reaction monitoring (SRM)⁷, offer high accuracy, making them valuable tools in clinical testing.⁸

High-performance liquid chromatography (HPLC) also plays an important role in protein quantification, offering high resolution and specificity. It enables the separation and quantification of individual proteins or peptides, often combined with UV 280 nm or fluorescence detection. Prevalent in pharmaceutical quality control and protein purity analysis, HPLC offers excellent reproducibility and precision though its throughput is limited compared to other methods.

Coupling of both HPLC and MS (HPLC-MS/MS) provides a unique capability for rapid, cost-effective, and quantitative measurement of complex samples, widely used in drug development for evaluation of drug metabolism and pharmacokinetics.^4,9,10

In the field of immunoassays, advanced platforms such as Luminex bead-based assays and Olink’s proximity extension assays (PEA)¹¹ enable high-throughput multiplex protein analysis from small sample volumes, and are highly valuable in biomarker discovery, clinical diagnostics, and long-term studies.

Table 1. Comparison of protein quantification methods by sensitivity, throughput, cost, and typical applications

Future directions

The field of proteomics is now dominated by large-scale data increasing demand for advanced digital tools such as cloud-based platforms and AI that can facilitate analysis of complex datasets.

Cloud-based platforms allow researchers to process large datasets without the limitations of local hardware, enabling real-time data sharing, collaborative analysis, and remote diagnostics. Platforms such as PeaksOnline, quantms, and CloudProteoAnalyzer, can provide intuitive web interfaces requiring minimum computational expertise, and support multi-user environments allowing collaborative analysis on large scale quantification projects with standardized pipelines and shared resources.^12-14 These platforms handle large MS datasets, allowing users to upload raw data, configure analysis parameters (e.g. TMT/iTRAQ) and distribute processing tasks across multiple computing nodes eliminating the need for local infrastructure.^12-14

AI is increasingly central to proteomics, enabling complex data analyses, enhancing MS data interpretation and predicting protein functions and interactions. Machine learning models, a subset of AI, can process raw MS data to identify and quantify proteins while deep learning models improve peptide identification by learning from large-scale spectral libraries, significantly increasing accuracy and throughput.^15,16 AI can also be used to denoise MS data by distinguishing real signal from background noise, improving data reliability.¹⁷ AlphaFold, an AI tool whose development won the Nobel prize in chemistry in 2024, has transformed protein structure prediction and exemplifies how these advances are contributing to more accurate, and effective protein quantification and analysis.¹⁸ Despite these advances, AI in proteomics is still in its infancy, limited by training data dependency, and deep learning “black boxes”, its outputs must be cautiously interpreted and experimentally validated by orthogonal methods.

Conclusion

Protein quantification has evolved from basic colorimetric methods to advanced, high-throughput technologies. Advancements in AI are transforming MS analysis enabling more accurate protein identification and quantification. These developments mark a shift toward integrative, data-driven protein analysis, creating a foundation for advancing biomedical research, and clinical therapies. As technologies expand, researchers must carefully evaluate and select the most appropriate assay based on the intended application, weighing the benefits and limitations of the assay.

References

1. Lowry O, Rosebrough N, Farr AL, Randall R. Protein Measurement with the Folin Phenol Reagent. J Biol Chem. 1951;193(1):265-275. doi:10.1016/S0021-9258(19)52451-6

2. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76-85. doi:10.1016/0003-2697(85)90442-7

3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1):248-254. doi:10.1016/0003-2697(76)90527-3

4. Song JG, Baral KC, Kim GL, et al. Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques. Drug Deliv. 2023;30(1):2183816. doi:10.1080/10717544.2023.2183816

5. Aydin S, Emre E, Ugur K, et al. An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids. J Int Med Res. 2025;53(2):03000605251315913. doi:10.1177/03000605251315913

6. Chen X, Sun Y, Zhang T, Shu L, Roepstorff P, Yang F. Quantitative Proteomics Using Isobaric Labeling: A Practical Guide. Genomics Proteomics Bioinformatics. 2021;19(5):689-706. doi:10.1016/j.gpb.2021.08.012

7. Zhi W, Wang M, She JX. Selected reaction monitoring (SRM) mass spectrometry without isotope labeling can be used for rapid protein quantification. Rapid Commun Mass Spectrom RCM. 2011;25(11):1583-1588. doi:10.1002/rcm.5023

8. Huillet C, Adrait A, Lebert D, et al. Accurate Quantification of Cardiovascular Biomarkers in Serum Using Protein Standard Absolute Quantification (PSAQTM) and Selected Reaction Monitoring*. Mol Cell Proteomics. 2012;11(2):M111.008235. doi:10.1074/mcp.M111.008235

9. Korfmacher WA. Foundation review: Principles and applications of LC-MS in new drug discovery. Drug Discov Today. 2005;10(20):1357-1367. doi:10.1016/S1359-6446(05)03620-2

10. Pitt JJ. Principles and Applications of Liquid Chromatography-Mass Spectrometry in Clinical Biochemistry. Clin Biochem Rev. 2009;30(1):19-34.

11. Zhong W, Edfors F, Gummesson A, Bergström G, Fagerberg L, Uhlén M. Next generation plasma proteome profiling to monitor health and disease. Nat Commun. 2021;12(1):2493. doi:10.1038/s41467-021-22767-z

12. Dai C, Pfeuffer J, Wang H, et al. quantms: a cloud-based pipeline for quantitative proteomics enables the reanalysis of public proteomics data. Nat Methods. 2024;21(9):1603-1607. doi:10.1038/s41592-024-02343-1

13. Li J, Xiong Y, Feng S, Pan C, Guo X. CloudProteoAnalyzer: scalable processing of big data from proteomics using cloud computing. Bioinforma Adv. 2024;4(1):vbae024. doi:10.1093/bioadv/vbae024

14. Xin L, Qiao R, Chen X, et al. A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics. Nat Commun. 2022;13(1):3108. doi:10.1038/s41467-022-30867-7

15. Swan AL, Mobasheri A, Allaway D, Liddell S, Bacardit J. Application of Machine Learning to Proteomics Data: Classification and Biomarker Identification in Postgenomics Biology. OMICS J Integr Biol. 2013;17(12):595-610. doi:10.1089/omi.2013.0017

16. Meyer JG. Deep learning neural network tools for proteomics. Cell Rep Methods. 2021;1(2):100003. doi:10.1016/j.crmeth.2021.100003

17. Beck AG, Muhoberac M, Randolph CE, et al. Recent Developments in Machine Learning for Mass Spectrometry. ACS Meas Sci Au. 2024;4(3):233-246. doi:10.1021/acsmeasuresciau.3c00060

18. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589. doi:10.1038/s41586-021-03819-2